Global & Public Health (all articles)
Transition to endemicity: Understanding COVID-19.
1 Oct, 2021 | 10:30h | UTCTransition to endemicity: Understanding COVID-19 – Cell
Related:
COVID will likely shift from pandemic to endemic — but what does that mean?
[Press release – Not published yet] Clover’s COVID-19 vaccine candidate demonstrates 79% efficacy against Delta.
30 Sep, 2021 | 10:30h | UTCCommentary: New Chinese vaccine could bolster global arsenal – Science
A pandemic recap: lessons we have learned.
30 Sep, 2021 | 10:29h | UTCA pandemic recap: lessons we have learned – World Journal of Emergency Surgery
Randomized trial with over 30.000 patients showed AstraZeneca vaccine was safe and resulted in 74% efficacy against symptomatic SARS-CoV-2 infection.
30 Sep, 2021 | 10:32h | UTC
Commentaries on Twitter
https://twitter.com/NEJM/status/1443331005050355715
https://twitter.com/EricTopol/status/1443336261897392133
World Heart Day 2021: COVID-19, digital health, and tackling cardiovascular disease.
30 Sep, 2021 | 10:20h | UTCWorld Heart Day 2021: COVID-19, digital health, and tackling cardiovascular disease – The Lancet
Commentary on Twitter
Cardiovascular disease (CVD) claims around 18.6 million lives every year. Could the rapid uptake of digital health during the pandemic transform the #CVD response?
On #WorldHeartDay🫀, a Comment from @fjpinto1960 and colleagues: https://t.co/4dF3I8MCEq pic.twitter.com/sQQg7kMbyC
— The Lancet (@TheLancet) September 29, 2021
Over a third of COVID-19 patients diagnosed with at least one long-COVID symptom.
30 Sep, 2021 | 10:25h | UTCNews release: Over a third of COVID-19 patients diagnosed with at least one long-COVID symptom – University of Oxford
Commentaries:
Two studies tie long COVID-19 to severe initial illness – CIDRAP
Covid: 37% of people have symptoms six months after infection – The Guardian
Long Covid is a bigger problem than we thought – CNN
Optimizing antimicrobial use in humans – review of current evidence and an interdisciplinary consensus on key priorities for research.
30 Sep, 2021 | 10:05h | UTC
CDC Study: Side effect rates from a third Covid-19 vaccine dose similar to those after second shot.
29 Sep, 2021 | 10:26h | UTC
Never Waste a Pandemic: Strategies to Increase Advance Care Planning Now.
29 Sep, 2021 | 10:22h | UTCNever Waste a Pandemic: Strategies to Increase Advance Care Planning Now – Mayo Clinic Proceedings
Opinion | Data from routine Covid testing can help schools stay open this year.
29 Sep, 2021 | 10:14h | UTCData from routine Covid testing can help schools stay open this year – STAT
Routine COVID testing doubles detection at 3 public schools.
29 Sep, 2021 | 10:16h | UTCRoutine COVID testing doubles detection at 3 public schools – CIDRAP
Original study: Assessment of a Program for SARS-CoV-2 Screening and Environmental Monitoring in an Urban Public School District – JAMA Network Open
Characterizing long COVID: a living systematic review.
29 Sep, 2021 | 10:29h | UTCCharacterising long COVID: a living systematic review – BMJ Global Health
Related:
Long Covid – The illness narratives.
New guidelines to help doctors manage long COVID patients published.
M-A: More than 50 long-term effects of COVID-19. (several articles on the subject)
Commentary on Twitter
https://twitter.com/CharitiniSt/status/1442528255718748164
Impact of the COVID-19 pandemic on transgender and gender diverse health care.
29 Sep, 2021 | 10:21h | UTC
WHO and partners call for urgent action on meningitis – New meningitis strategy aims to save more than 200,000 lives annually.
29 Sep, 2021 | 10:06h | UTCSee guidance: Defeating meningitis by 2030: a global road map – World Health Organization
Commentaries:
WHO Launches First Global Strategy to Eliminate Bacterial Meningitis by 2030 – Health Policy Watch
Commentary on Twitter (thread – click for more)
🆕! First ever global strategy to #DefeatMeningitis – a debilitating disease that kills hundreds of thousands of people each year. 👉https://t.co/wG6CqmOPH1 pic.twitter.com/0q6fkTwRHm
— World Health Organization (WHO) (@WHO) September 28, 2021
Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990–2019, for 204 countries and territories: the Global Burden of Diseases Study 2019.
29 Sep, 2021 | 09:56h | UTC
Commentary on Twitter (thread – click for more)
🗨️2019 #GBDstudy examines the #global, regional, and national sex-specific burden and control of the #HIV epidemic from 1990-2019 for #204 countries and territories.
Read more from @TheLancet here⬇️https://t.co/d4s6Hw8uDX
— Institute for Health Metrics and Evaluation (IHME) (@IHME_UW) September 27, 2021
Editorial: It’s time to send children back to school.
28 Sep, 2021 | 09:49h | UTCIt’s time to send children back to school – Nature Medicine
COVID-19 testing moves out of the clinic and into the home.
28 Sep, 2021 | 09:46h | UTCCOVID-19 Testing Moves Out of the Clinic and Into the Home – JAMA
Study shows COVID-19 has caused the biggest decrease in life expectancy since World War II.
28 Sep, 2021 | 09:51h | UTCNews release: COVID-19 has caused the biggest decrease in life expectancy since World War II – University of Oxford
Commentaries:
Life expectancy falls in 27 of 29 nations amid COVID-19 – CIDRAP
Covid has wiped out years of progress on life expectancy, finds study – The Guardian
Related:
Just how do deaths due to COVID-19 stack up?
Exploring the gap between excess mortality and COVID-19 deaths in 67 countries.
COVID-19 has caused 6.9 million deaths globally, more than double what official reports show
Commentary on Twitter
The Covid-19 pandemic has resulted in the largest loss of life expectancy since World War II, worst among American menhttps://t.co/7eNCkwBuJA @jm_aburto @UniofOxford @OxfordDemSci @ridhikash07 @melindacmills pic.twitter.com/ckRIDD9G4m
— Eric Topol (@EricTopol) September 27, 2021
Evidence shows that, yes, masks prevent COVID-19 – and surgical masks are the way to go.
28 Sep, 2021 | 09:45h | UTCRelated: [Preprint] Largest study of masks yet details their importance in fighting Covid-19.
Functioning of the international health regulations during the COVID-19 pandemic.
28 Sep, 2021 | 09:41h | UTCFunctioning of the International Health Regulations during the COVID-19 pandemic – The Lancet
Systematic review: Can non-pharmacological measures prevent or reduce Covid-19 (SARS-CoV-2) infections in long term care facilities?
28 Sep, 2021 | 09:47h | UTC
Review: The biological and clinical significance of emerging SARS-CoV-2 variants.
28 Sep, 2021 | 09:43h | UTCThe biological and clinical significance of emerging SARS-CoV-2 variants – Nature Reviews Genetics
Commentary on Twitter
A Review in @NatureRevGenet describes the latest understanding of the emergence and properties of SARS-CoV-2 genetic variants, particularly those designated as WHO “variants of concern.” https://t.co/MUERXQRQxd pic.twitter.com/6dsHEMmk2p
— Nature Portfolio (@NaturePortfolio) September 22, 2021
New analysis shows use and predictors of low-value care in health systems – “Patients at health systems with smaller shares of primary care physicians and without teaching hospitals were more likely to receive low-value services”.
28 Sep, 2021 | 09:08h | UTCNews release: New analysis shows use and predictors of low-value care in health systems nationwide – Brigham and Women’s Hospital
Original study: Low-Value Care at the Actionable Level of Individual Health Systems – JAMA Internal Medicine
Author interview: Low-Value Care at the Actionable Level of Individual Health Systems
Commentary on Twitter
New study measures and reports use of 41 low-value care services + composite measure for 556 health systems across US. More low-value care in systems w ↓ PCPs, w/o major teaching hospital, HQ'ed in South+West, in areas w ↑ healthcare spending https://t.co/0qdkflxwWF
— JAMA Internal Medicine (@JAMAInternalMed) September 27, 2021
Drug-resistant malaria is gaining a foothold in Africa – “Analyses of patient blood samples suggest artemisinin effectiveness is slipping”.
28 Sep, 2021 | 08:49h | UTCDrug-resistant malaria is gaining a foothold in Africa – Science
Commentary on Twitter
Drug-evading parasites appeared in Southeast Asia in the early 2000s, eventually leading to failures of key therapies.
But the stakes are higher for Africa, home to 94% of both malaria cases and deaths worldwide in 2019. https://t.co/ILamXKP3yh
— Global Health NOW (@ghn_news) September 27, 2021
Updated WHO Living Guideline: Therapeutics and COVID-19.
26 Sep, 2021 | 22:16h | UTCTherapeutics and COVID-19: living guideline – World Health Organization
WHO Statement: On new recommendation for treatment of COVID-19 patients: WHO calls for equitable access to casirivimab and imdevimab for COVID-19
See also:
WHO recommends antibody treatment for COVID patients at high risk of hospital admission.
Commentary: WHO adds new recommendation for COVID-19 monoclonal antibody combo – CIDRAP